Provided by Tiger Trade Technology Pte. Ltd.

Redhill Biopharma

0.4908
+0.01082.25%
Volume:113.04K
Turnover:56.04K
Market Cap:2.98M
PE:-3.61
High:0.5150
Open:0.5150
Low:0.4881
Close:0.4800
52wk High:2.60
52wk Low:0.4647
Shares:6.08M
Float Shares:6.08M
Volume Ratio:0.60
T/O Rate:1.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1358
EPS(LYR):-0.1358
ROE:-1708.61%
ROA:-22.37%
PB:-2.77
PE(LYR):-3.61

Loading ...

RedHill Biopharma's Opaganib Gains FDA Rare Pediatric Disease Status for Neuroblastoma

MT Newswires Live
·
Jun 09

RedHill says FDA grants opaganib rare pediatric disease designation for neuroblastoma

Reuters
·
Jun 09

RedHill Biopharma launches enforcement of $11M judgment against Kukbo

TIPRANKS
·
Jun 08

Redhill Biopharma Advances Opaganib Options For Ebola Virus Disease Outbreak

Reuters
·
Jun 04

RedHill Biopharma discusses adding opaganib to WHO Ebola trial platform

Reuters
·
Jun 04

RedHill Biopharma - Actively Discussing Potential Collaborations For Advancement Of Its Investigational Oral Drug, Opaganib

Reuters
·
Jun 02

RedHill Biopharma explores opaganib entry into WHO SOLIDARITY CORE Ebola trial platform

Reuters
·
Jun 02

RedHill Biopharma boosts maximum size of ATM ADS offering with H.C. Wainwright

Reuters
·
May 28

RedHill Biopharma releases corporate presentation on GI, infectious disease and oncology pipeline

Reuters
·
May 17

RedHill Biopharma publishes corporate presentation on GI, infectious disease, oncology pipeline

Reuters
·
Apr 29

Redhill Biopharma FY EPS $0.00, Sales $286.000K Down From $8.043M YoY

Benzinga Earnings
·
Apr 27

RedHill Biopharma FY25 operating loss widens to USD 7.9 million; revenue rises to USD 286,000

Reuters
·
Apr 27

RedHill Biopharma announces presentation of preclinical data on opaganib at AACR

TIPRANKS
·
Apr 22

RedHill Biopharma publishes corporate presentation on GI, infectious disease and oncology pipeline

Reuters
·
Apr 20

RedHill Biopharma gets Nasdaq notice after ADS bid price stays below $1

Reuters
·
Apr 14